Alto Neuroscience, Inc. (ANRO)
USD 3.64
(-3.96%)
USD 3.64
(-3.96%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -33.44 Million | -20.39 Million | -9.26 Million |
| Net Income | -36.3 Million | -27.71 Million | -9.18 Million |
| Depreciation & Amortization | 373 Thousand | 342 Thousand | 145 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 2.89 Million | 1.76 Million | 227 Thousand |
| Change in working capital | -698 Thousand | 4.57 Million | -572 Thousand |
| Other non-cash items | 4.23 Million | 915 Thousand | 1.46 Million |
| Investing Cash Flow | -470 Thousand | -732 Thousand | -680 Thousand |
| Investments in PPE | -470 Thousand | -732 Thousand | -680 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -470 Thousand | - | - |
| Financing Cash Flow | 68.13 Million | 43.78 Million | 31.68 Million |
| Debt repayment | - | -9.67 Million | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 69.52 Million | 34.11 Million | 31.68 Million |
| Other Financing Activities | -1.39 Million | -341 Thousand | -205 Thousand |
| Accounts receivables | 325 Thousand | 1.15 Million | -1.28 Million |
| Accounts payables | -632 Thousand | 1 Million | 458 Thousand |
| Inventory | - | - | - |
| Other working capital | -391 Thousand | 2.41 Million | 255 Thousand |
| Cash at beginning of period | 48.34 Million | 25.7 Million | 4 Million |
| Cash at end of period | 82.54 Million | 48.34 Million | 25.7 Million |
| Capital Expenditure | -470 Thousand | -732 Thousand | -680 Thousand |
| Effect of forex changes on cash | -8000.00 | -24 Thousand | -50 Thousand |
| Net cash flow / Change in cash | 34.2 Million | 22.63 Million | 21.69 Million |
| Free Cash Flow | -33.91 Million | -21.12 Million | -9.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.03 Million | -13.41 Million | -36.3 Million | -11.21 Million | -9.14 Million | -8.66 Million |
| Depreciation & Amortization | 100 Thousand | 97 Thousand | 373 Thousand | 92 Thousand | 83 Thousand | 100 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.88 Million | 2.17 Million | 2.89 Million | 606 Thousand | 541 Thousand | 1.26 Million |
| Change in working capital | 1.43 Million | -255 Thousand | -698 Thousand | -1.15 Million | 834 Thousand | 600 Thousand |
| Other non-cash items | 3.25 Million | 1.65 Million | 4.23 Million | 177 Thousand | 164 Thousand | 22 Thousand |
| Investing Cash Flow | -340 Thousand | -224 Thousand | -470 Thousand | -352 Thousand | -43 Thousand | -54 Thousand |
| Investments in PPE | -340 Thousand | -224 Thousand | -470 Thousand | -352 Thousand | -43 Thousand | -54 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -340 Thousand | - | - | - | - | - |
| Financing Cash Flow | -234 Thousand | 134.55 Million | 68.13 Million | 43.13 Million | 49 Thousand | -51 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -234 Thousand | 134.55 Million | 69.52 Million | 29 Thousand | 152 Thousand | -51 Thousand |
| Other Financing Activities | -295 Thousand | -3.03 Million | -1.39 Million | -1.89 Million | - | - |
| Accounts receivables | - | 8000.00 | 325 Thousand | -30 Thousand | - | 67 Thousand |
| Accounts payables | -251 Thousand | 1.12 Million | -632 Thousand | -781 Thousand | -641 Thousand | 1.43 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.68 Million | -1.38 Million | -391 Thousand | -375 Thousand | - | -906 Thousand |
| Cash at beginning of period | 205.89 Million | 82.54 Million | 48.34 Million | 51.28 Million | 59.02 Million | 65.78 Million |
| Cash at end of period | 193.12 Million | 205.89 Million | 82.54 Million | 82.54 Million | 51.28 Million | 59.02 Million |
| Capital Expenditure | -340 Thousand | -224 Thousand | -470 Thousand | -352 Thousand | -43 Thousand | -54 Thousand |
| Effect of forex changes on cash | -5000.00 | -5000.00 | -8000.00 | 4000.00 | 18 Thousand | -11 Thousand |
| Net cash flow / Change in cash | -12.77 Million | 123.34 Million | 34.2 Million | 31.26 Million | -7.74 Million | -6.75 Million |
| Free Cash Flow | -12.03 Million | -11.2 Million | -33.91 Million | -11.87 Million | -7.8 Million | -6.68 Million |
FCH
CROX
OFG
MOPHY
BIOT
GTY